Federation Des Caisses Desjardins Du Quebec Recursion Pharmaceuticals, Inc. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $18.4 Billion
- Q4 2024
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 43,091 shares of RXRX stock, worth $458,488. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43,091
Previous 42,500
1.39%
Holding current value
$458,488
Previous $280,000
3.93%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding RXRX
# of Institutions
337Shares Held
284MCall Options Held
2.83MPut Options Held
3.64M-
Vanguard Group Inc Valley Forge, PA34MShares$362 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.3MShares$344 Million1.91% of portfolio
-
Baillie Gifford & CO24.9MShares$265 Million0.13% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$184 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$156 Million0.44% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.92B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...